PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 118 filers reported holding PHATHOM PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $59,874 | +872.0% | 5,813 | +902.2% | 0.00% | – |
| Q1 2024 | $6,160 | -93.2% | 580 | -94.1% | 0.00% | -100.0% |
| Q4 2023 | $90,031 | -6.8% | 9,861 | +5.9% | 0.00% | -66.7% |
| Q3 2023 | $96,556 | +1313.7% | 9,311 | +1852.0% | 0.00% | – |
| Q2 2023 | $6,830 | +56816.7% | 477 | -72.0% | 0.00% | – |
| Q1 2023 | $12 | +140.0% | 1,705 | +250.8% | 0.00% | – |
| Q4 2022 | $5 | -100.0% | 486 | -89.1% | 0.00% | -100.0% |
| Q3 2022 | $49,000 | +8.9% | 4,451 | -17.3% | 0.00% | 0.0% |
| Q2 2022 | $45,000 | -11.8% | 5,380 | +45.6% | 0.00% | – |
| Q1 2022 | $51,000 | +537.5% | 3,696 | +788.5% | 0.00% | – |
| Q4 2021 | $8,000 | -57.9% | 416 | -31.4% | 0.00% | – |
| Q3 2021 | $19,000 | -85.4% | 606 | -84.2% | 0.00% | -100.0% |
| Q2 2021 | $130,000 | +165.3% | 3,833 | +191.3% | 0.00% | +200.0% |
| Q1 2021 | $49,000 | -31.9% | 1,316 | -39.0% | 0.00% | -50.0% |
| Q4 2020 | $72,000 | -82.5% | 2,157 | -80.8% | 0.00% | -60.0% |
| Q3 2020 | $411,000 | +478.9% | 11,212 | +420.5% | 0.01% | +66.7% |
| Q2 2020 | $71,000 | – | 2,154 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 7,464,572 | $76,885,092 | 22.93% |
| Propel Bio Management, LLC | 869,927 | $8,960,248 | 5.81% |
| Catalys Pacific, LLC | 721,962 | $7,436,208 | 5.61% |
| Checkpoint Capital L.P. | 875,000 | $9,012,500 | 5.43% |
| Frazier Life Sciences Management, L.P. | 10,109,279 | $104,125,574 | 4.87% |
| Carlyle Group Inc. | 3,496,808 | $35,842,282 | 3.40% |
| Decheng Capital LLC | 850,000 | $8,755,000 | 2.68% |
| Saturn V Capital Management LP | 593,306 | $6,111,052 | 2.31% |
| ORACLE INVESTMENT MANAGEMENT INC | 225,000 | $2,317,500 | 2.16% |
| Ghost Tree Capital, LLC | 600,000 | $6,180,000 | 1.94% |